Robert J. Spiegel - Jun 13, 2022 Form 4 Insider Report for Ayala Pharmaceuticals, Inc. (AYLA)

Role
Director
Signature
/s/ Roni Mamluk, Ph.D., Attorney-in-Fact for Robert J. Spiegel, M.D.
Stock symbol
AYLA
Transactions as of
Jun 13, 2022
Transactions value $
$0
Form type
4
Date filed
6/15/2022, 04:15 PM
Previous filing
May 11, 2022
Next filing
Jun 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AYLA Stock Option (Right to Buy) Award $0 +6.25K $0.00 6.25K Jun 13, 2022 Common Stock 6.25K $1.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable on the earlier of (i) June 13, 2023 or (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.